CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT

CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT

the article presents the results of a retrospective study conducted in the period from 2008 to 2011 in Moscow’s hospitals. The aim of the study was to compare the clinical and pharmacoeconomical efficacy of carbapenems in nosocomial pneumonia treatment. The study included 87 patients divided into 3...

Full description

Bibliographic Details
Main Authors: I. I. Shteynberg, S. K. Zyryanov, Yu. B. Belousov
Format: Article
Language:Russian
Published: IRBIS LLC 2015-03-01
Series:Фармакоэкономика
Subjects:
nosocomial pneumonia
carbapenem
meropenem
imipenem
doripenem
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/54
id doaj-739d99d3ee8147ec8c08ef2ef51f8f4a
record_format Article
spelling doaj-739d99d3ee8147ec8c08ef2ef51f8f4a2021-07-28T13:30:39ZrusIRBIS LLCФармакоэкономика2070-49092070-49332015-03-0171141848CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENTI. I. Shteynberg0S. K. Zyryanov1Yu. B. Belousov2The Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of the Russian Federation, MoscowThe Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of the Russian Federation, MoscowThe Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of the Russian Federation, Moscowthe article presents the results of a retrospective study conducted in the period from 2008 to 2011 in Moscow’s hospitals. The aim of the study was to compare the clinical and pharmacoeconomical efficacy of carbapenems in nosocomial pneumonia treatment. The study included 87 patients divided into 3 groups according to the therapy (imipenem, meropenem, doripenem). There were no statistically significant differences in clinical efficacy of carbapenems. Pharmacoeconomic analysis showed more profitable use of imipenem.https://www.pharmacoeconomics.ru/jour/article/view/54nosocomial pneumoniacarbapenemmeropenemimipenemdoripenem
collection DOAJ
language Russian
format Article
sources DOAJ
author I. I. Shteynberg
S. K. Zyryanov
Yu. B. Belousov
spellingShingle I. I. Shteynberg
S. K. Zyryanov
Yu. B. Belousov
CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT
Фармакоэкономика
nosocomial pneumonia
carbapenem
meropenem
imipenem
doripenem
author_facet I. I. Shteynberg
S. K. Zyryanov
Yu. B. Belousov
author_sort I. I. Shteynberg
title CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT
title_short CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT
title_full CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT
title_fullStr CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT
title_full_unstemmed CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT
title_sort clinical and pharmacoeconomic analysis of carbapenems (meropenem, imipenem and doripenem) in nosocomial pneumonia treatment
publisher IRBIS LLC
series Фармакоэкономика
issn 2070-4909
2070-4933
publishDate 2015-03-01
description the article presents the results of a retrospective study conducted in the period from 2008 to 2011 in Moscow’s hospitals. The aim of the study was to compare the clinical and pharmacoeconomical efficacy of carbapenems in nosocomial pneumonia treatment. The study included 87 patients divided into 3 groups according to the therapy (imipenem, meropenem, doripenem). There were no statistically significant differences in clinical efficacy of carbapenems. Pharmacoeconomic analysis showed more profitable use of imipenem.
topic nosocomial pneumonia
carbapenem
meropenem
imipenem
doripenem
url https://www.pharmacoeconomics.ru/jour/article/view/54
work_keys_str_mv AT iishteynberg clinicalandpharmacoeconomicanalysisofcarbapenemsmeropenemimipenemanddoripeneminnosocomialpneumoniatreatment
AT skzyryanov clinicalandpharmacoeconomicanalysisofcarbapenemsmeropenemimipenemanddoripeneminnosocomialpneumoniatreatment
AT yubbelousov clinicalandpharmacoeconomicanalysisofcarbapenemsmeropenemimipenemanddoripeneminnosocomialpneumoniatreatment
_version_ 1721273374508843008

Similar Items